Pharmaceutical Technology

MAY 22, 2023

This new facility complements the bioprocess design centre and customer experience centre, the two operational lab facilities of Thermo Fisher with the latest life science, analytical, and bioprocessing technologies. The bioprocess design centre offers expertise in bioprocessing and process scale-up.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccination 147

Drug Discovery Today

AUGUST 5, 2021

(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.

Genetic Analysis 40

Genetic Analysis Genome Genomics Genetics 40

XTalks

MARCH 7, 2024

The webinar provides insights into a novel method that facilitates detailed genetic analysis of breast cancer, marrying the depth of whole-genome studies with the precision of targeted analysis at the single-cell level. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.

Genetics 115

Genetics Hormones Genomics Genome 115

XTalks

DECEMBER 1, 2020

Integrated technologies, such as the Research Use Only platform, DEPArray™*, allow for the further exploration of precision medicine by allowing researchers to easily identify and isolate single cells for downstream genetic analysis.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

JULY 29, 2024

Next-generation sequencing (NGS) allows for efficient analysis of known genetic mutations, enhancing diagnostic accuracy. Overall, the diagnostic process for LOPD typically involves a series of assessments, including clinical, laboratory and imaging tests, culminating in genetic analysis to confirm the diagnosis.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Research 105

XTalks

JANUARY 6, 2025

NGS technology has revolutionized genetic analysis, enabling laboratories to rapidly sequence whole genomes, deeply sequence target regions and identify novel pathogens. The global NGS market is projected to grow from $13.0 billion in 2022 to $27.0 billion by 2027, with an estimated growth rate of 15.7 percent over this period.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111